Best Clinical Practice: Current Controversies in Pulmonary Embolism Imaging and Treatment of Subsegmental Thromboembolic Disease

Journal of Emergency Medicine

Volumn 52, Issue 2, 2017, Pages 184-193

  Long, Brit ^a   Koyfman, Alex ^b  

^a SAN ANTONIO MILITARY MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

anticoagulation; computed tomography; incidental; pulmonary embolism; subsegmental

Indexed keywords

ANTICOAGULANT AGENT; D DIMER; APIXABAN; DABIGATRAN; EDOXABAN; PYRAZOLE DERIVATIVE; PYRIDINE DERIVATIVE; PYRIDONE DERIVATIVE; RIVAROXABAN; THIAZOLE DERIVATIVE;

ANTICOAGULANT THERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST INDUCED NEPHROPATHY; DEEP VEIN THROMBOSIS; DIAGNOSTIC IMAGING; EMERGENCY CARE; EMERGENCY PHYSICIAN; EVIDENCE BASED EMERGENCY MEDICINE; HIGH RISK PATIENT; HUMAN; INCIDENTAL FINDING; LOW RISK PATIENT; LUNG EMBOLISM; MEDICAL LITERATURE; NOTE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIATION EXPOSURE; RECURRENT DISEASE; RISK ASSESSMENT; SUBSEGMENTAL PULMONARY EMBOLISM; VENOUS THROMBOEMBOLISM; DECISION MAKING; OUTCOME ASSESSMENT; PROCEDURES; PULMONARY EMBOLISM; RISK FACTOR; X-RAY COMPUTED TOMOGRAPHY;

ANTICOAGULANTS; DABIGATRAN; DECISION MAKING; HUMANS; PATIENT OUTCOME ASSESSMENT; PULMONARY EMBOLISM; PYRAZOLES; PYRIDINES; PYRIDONES; RISK ASSESSMENT; RISK FACTORS; RIVAROXABAN; THIAZOLES; TOMOGRAPHY, X-RAY COMPUTED; VENOUS THROMBOEMBOLISM;

EID: 84992402749     PISSN: 07364679     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jemermed.2016.08.021     Document Type: Note

References (86)

1. 1 Barritt, D.W., Jordan, S.C., Anticoagulant drugs in the treatment of pulmonary embolism: a controlled trial. Lancet 1 (1960), 1309–1312.
2. 2 Cushman, M., Tsai, A.W., White, R.H., et al. Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. Am J Med 117 (2004), 19–25.
3. 3 Heit, J.A., The epidemiology of venous thromboembolism in the community: implications for prevention and management. J Thromb Haemost 21 (2006), 23–29.
4. 4 Chunilal, S.D., Eikelboom, J.W., Attia, J., et al. Does this patient have pulmonary embolism?. JAMA 290 (2003), 2849–2858.
5. 5 Carrier, M., Righini, M., Le, G.G., Symptomatic subsegmental pulmonary embolism: what is the next step?. J Thromb Haemost 10 (2012), 1486–1490.
6. 6 Carrier, M., Righini, M., Wells, P.S., et al. Subsegmental pulmonary embolism diagnosed by computed tomography: incidence and clinical implications. A systematic review and meta-analysis of the management outcome studies. J Thromb Haemost 8 (2010), 1716–1722.
7. 7 Raskob, G.E., Importance of subsegmental pulmonary embolism. Blood 122 (2015), 1095–1096.
8. 8 Raja, A.S., Greenberg, J.O., Qaseem, A., et al. Evaluation of patients with suspected acute pulmonary embolism: best practice advice from the Clinical Guidelines Committee of the American College of Physicians. Ann Intern Med 163 (2015), 701–711.
9. 9 Kline, J.A., Kabrhel, C., Emergency evaluation for pulmonary embolism, part 2: diagnostic approach. J Emerg Med 49 (2015), 104–117.
10. 10 Kearon, C., Akl, E.A., Ornelas, J., et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest 149 (2016), 315–352.
11. 11 Green, S.M., Yealy, D.M., Right-sizing testing for pulmonary embolism: recognizing the risks of detecting any clot. Ann Emerg Med 59 (2012), 524–526.
12. 12 Stein, P.D., Fowler, S.E., Goodman, L.R., et al. Multidetector computed tomography for acute pulmonary embolism. N Engl J Med 354 (2006), 2317–2327.
13. 13 Mullins, M.D., Becker, D.M., Hagspiel, K.D., Philbrick, J.T., The role of spiral volumetric computed tomography in the diagnosis of pulmonary embolism. Arch Intern Med 160 (2000), 293–298.
14. 14 Rathbun, S.W., Raskob, G.E., Whitsett, T.L., Sensitivity and specificity of helical computed tomography in the diagnosis of pulmonary embolism: a systematic review. Ann Intern Med 132 (2000), 227–232.
15. 15 Le Gal, G., Righini, M., Parent, F., van Strijen, M., Couturaud, F., Diagnosis and management of sub-segmental pulmonary embolism. J Thromb Haemost 4 (2006), 724–731.
16. 16 Wiener, R.S., Schwartz, L.M., Woloshin, S., When a test is too good: how CT pulmonary angiograms find pulmonary emboli that do not need to be found. BMJ, 347, 2013, f3368.
17. 17 Weiss, C.R., Scatarige, J.C., Diette, G.B., Haponik, E.F., Merriman, B., Fishman, E.K., CT pulmonary angiography is the first-line imaging test for acute pulmonary embolism: a survey of US clinicians. Acad Radiol 13 (2006), 434–446.
18. 18 Smith-Bindman, R., Miglioretti, D.L., Johnson, E., et al. Use of diagnostic imaging studies and associated radiation exposure for patients enrolled in large integrated health care systems, 1996-2010. JAMA 307 (2012), 2400–2409.
19. 19 Adams, D.M., Stevens, S.M., Woller, S.C., et al. Adherence to PIOPED II investigators’ recommendations for computed tomography pulmonary angiography. Am J Med 126 (2013), 36–42.
20. 20 Ikesaka, R., Carrier, M., Clinical significance and management of subsegmental pulmonary embolism. J Thromb Thrombolysis 39 (2015), 311–314.
21. 21 Wiener, R.S., Schwartz, L.M., Woloshin, S., Time trends in pulmonary embolism in the United States: evidence of overdiagnosis. Arch Intern Med 171 (2011), 831–837.
22. 22 Ghaye, B., Peripheral pulmonary embolism on multidetector CT pulmonary angiography. JBR-BTR 90 (2007), 100–108.
23. 23 Ghaye, B., Szapiro, D., Mastora, I., et al. Peripheral pulmonary arteries: how far in the lung does multi- detector row spiral CT allow analysis?. Radiology 219 (2001), 629–636.
24. 24 Raptopoulos, V., Boiselle, P.M., Multi-detector row spiral CT pulmonary angiography: comparison with single-detector row spiral CT. Radiology 221 (2001), 606–613.
25. 25 Burnside, P., Kline, J.A., Indirect computed tomography venography: quality of vascular opacification and diagnostic implications. Emerg Radiol 17 (2010), 195–202.
26. 26 Mos, I.C., Klok, F.A., Kroft, L.J., et al. Safety of ruling out acute pulmonary embolism by normal computed tomography pulmonary angiography in patients with an indication for computed tomography: systematic review and meta-analysis. J Thromb Haemost 7 (2009), 1491–1498.
27. 27 Pesavento, R., de Conti, G., Minotto, I., et al. The value of 64-detector row computed tomography for the exclusion of pulmonary embolism. Thromb Haemost 105 (2011), 901–907.
28. 28 Kline, J.A., Courtney, D.M., Beam, D.M., et al. Incidence and predictors of repeated computed tomographic pulmonary angiography in emergency department patients. Ann Emerg Med 54 (2009), 41–48.
29. 29 Amis, E.S. Jr., Butler, P.F., Applegate, K.E., et al. American College of Radiology white paper on radiation dose in medicine. J Am Coll Radiol 4 (2007), 272–284.
30. 30 Brenner, D.J., Hall, E.J., Computed tomography—an increasing source of radiation exposure. N Engl J Med 357 (2007), 2277–2284.
31. 31 Einstein, A.J., Henzlova, M.J., Rajagopalan, S., Estimating risk of cancer associated with radiation exposure from 64-slice computed tomography coronary angiography. JAMA 298 (2007), 317–323.
32. 32 Health Physics Society, Radiation exposure from medical diagnostic imaging procedures Health Physics Society fact sheet. 2008, Health Physics Society, McLean, VA.
33. 33 Parker, M.S., Hui, F.K., Camacho, M.A., et al. Female breast radiation exposure during CT pulmonary angiography. AJR Am J Roentgenol 185 (2005), 1228–1233.
34. 34 Kopp, A.F., Mortele, K.J., Cho, Y.D., et al. Prevalence of acute reactions to iopromide: postmarketing surveillance study of 74,717 patients. Acta Radiol 49 (2008), 902–911.
35. 35 Mitchell, A.M., Jones, A.E., Tumlin, J.A., et al. Immediate complications of intravenous contrast for computed tomography imaging in the outpatient setting are rare. Acad Emerg Med 18 (2011), 1005–1009.
36. 36 Mitchell, A.M., Jones, A.E., Tumlin, J.A., Kline, J.A., Incidence of contrast-induced nephropathy after contrast-enhanced computed tomography in the outpatient setting. Clin J Am Soc Nephrol 5 (2010), 4–9.
37. 37 Mitchell, A.M., Jones, A.E., Tumlin, J.A., Kline, J.A., Prospective study of the incidence of contrast-induced nephropathy among patients evaluated for pulmonary embolism by contrast-enhanced computed tomography. Acad Emerg Med 19 (2012), 618–625.
38. 38 Sinert, R., Brandler, E., Subramanian, R.A., et al. Does the current definition of contrast-induced acute kidney injury reflect a true clinical entity?. Acad Emerg Med 19 (2012), 1261–1267.
39. 39 Park, B., Messina, L., Dargon, P., Huang, W., Ciocca, R., Anderson, F.A., Recent trends in clinical outcomes and resource utilization for pulmonary embolism in the United States: findings from the nationwide inpatient sample. Chest 136 (2009), 983–990.
40. 40 Bullano, M.F., Willey, V., Hauch, O., Wygant, G., Spyropoulos, A.C., Hoffman, L., Longitudinal evaluation of health plan cost per venous thromboembolism or bleed event in patients with a prior venous thromboembolism event during hospitalization. J Manag Care Pharm 11 (2005), 663–673.
41. 41 Sebastian, A.J., Paddon, A.J., Clinically unsuspected pulmonary embolism: an important secondary finding in oncology CT. Clin Radiol 61 (2006), 81–85.
42. 42 Verschakelen, J.A., Vanwijck, E., Bogaert, J., et al. Detection of unsuspected central pulmonary embolism with conventional contrast-enhanced CT. Radiology 188 (1993), 847–850.
43. 43 Patel, J.J., Chandrasekaran, K., Maniet, A.R., et al. Impact of incidental diagnosis of clinically unsuspected central pulmonary artery thromboembolism in treatment of critically ill patients. Chest 105 (1994), 986–990.
44. 44 Winston, C.B., Wechsler, R.J., Salazar, A.M., et al. Incidental pulmonary emboli detected at helical CT: effect on patient care. Radiology 201 (1996), 23–27.
45. 45 Gosselin, M.V., Rubin, G.D., Leung, A.N., et al. Unsuspected pulmonary embolism: prospective detection on routine helical CT scans. Radiology 208 (1998), 209–215.
46. 46 Storto, M.L., Di Credico, A., Guido, F., et al. Incidental detection of pulmonary emboli on routine MDCT of the chest. AJR Am J Roentgenol 184 (2005), 264–267.
47. 47 Engelke, C., Manstein, P., Rummeny, E.J., et al. Suspected and incidental pulmonary embolism on multidetector-row CT: analysis of technical and morphological factors influencing the diagnosis in a cross-sectional cancer centre patient cohort. Clin Radiol 61 (2006), 71–80.
48. 48 Gladish, G.W., Choe, D.H., Marom, E.M., et al. Incidental pulmonary emboli in oncology patients: prevalence, CT evaluation, and natural history. Radiology 240 (2006), 246–255.
49. 49 Ritchie, G., McGurk, S., McCreath, C., et al. Prospective evaluation of unsuspected pulmonary embolism on contrast enhanced CT (MDCT) scanning. Thorax 62 (2007), 536–540.
50. 50 Desai, S.R., Unsuspected pulmonary embolism on CT scanning: yet another headache for clinicians?. Thorax 62 (2007), 470–472.
51. 51 Ghanima, W., Nielssen, B.E., Holmen, L.O., Witwit, A., Al-Ashtari, A., Sandset, P.M., Multidetector computed tomography (MDCT) in the diagnosis of pulmonary embolism: interobserver agreement among radiologists with varied levels of experience. Acta Radiol 48 (2007), 165–170.
52. 52 Perrier, A., Desmarais, S., Miron, M.J., et al. Non-invasive diagnosis of venous thromboembolism in outpatients. Lancet 353 (1999), 190–195.
53. 53 Hutchinson, B.D., Navin, P., Marom, E.M., et al. Overdiagnosis of pulmonary embolism by pulmonary CT angiography. AJR Am J Roentgenol 205 (2015), 271–277.
54. 54 Gurney, J.W., No fooling around: direct visualisation of pulmonary embolism. Radiology 188 (1993), 618–619.
55. 55 Miller, W.T. Jr., Marinari, L.A., Barbosa, E. Jr., et al. Small pulmonary artery defects are not reliable indicators of pulmonary embolism. Ann Am Thorac Soc 12 (2015), 1022–1029.
56. 56 Courtney, D.M., Miller, C.D., Smithline, H.A., et al. Prospective multicenter assessment of interobserver agreement for radiologist interpretation of multidetector CT angiography for pulmonary embolism. J Thromb Haemost 8 (2010), 533–540.
57. 57 Goodman, L.R., Small pulmonary emboli: what do we know?. Radiology 23 (2005), 654–658.
58. 58 Stein, P.D., Henry, J.W., Prevalence of acute pulmonary embolism among patients in a general hospital and at autopsy. Chest 108 (1995), 978–981.
59. 59 Bergqvist, D., Lindblad, B., A 30-year survey of pulmonary embolism verified at autopsy: an analysis of 1274 surgical patients. Br J Surg 72 (1985), 105–108.
60. 60 Cullen, D.J., Nemeskal, A.R., The autopsy incidence of acute pulmonary embolism in critically ill surgical patients. Intensive Care Med 12 (1986), 399–403.
61. 61 Lindblad, B., Sternby, N.H., Bergqvist, D., Incidence of venous thromboembolism verified by necropsy over 30 years. BMJ 302 (1991), 709–711.
62. 62 Lindblad, B., Eriksson, A., Bergqvist, D., Autopsy-verified pulmonary embolism in a surgical department: analysis of the period from 1951 to 1988. Br J Surg 78 (1991), 849–852.
63. 63 Engelke, C., Rummeny, E.J., Marten, K., Pulmonary embolism at multi-detector row CT of chest: one- year survival of treated and untreated patients. Radiology 239 (2006), 563–575.
64. 64 Eyer, B.A., Goodman, L.R., Washington, L., Clinicians’ response to radiologists’ reports of isolated subsegmental pulmonary embolism or inconclusive interpretation of pulmonary embolism using MDCT. AJR Am J Roentgenol 184 (2005), 623–628.
65. 65 den Exter, P.L., van Es, J., Klok, F.A., et al. Risk profile and clinical outcome of symptomatic subsegmental acute pulmonary embolism. Blood 122 (2013), 1144–1149.
66. 66 Yoo, H.H.B., Queluz, T.H.A.T., El Dib, R., Anticoagulant treatment for subsegmental pulmonary embolism. Cochrane Database Syst Rev, 1, 2016, CD010222.
67. 67 Buller, H.R., Prins, M.H., Lensing, A.W., et al. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med 366 (2012), 1287–1297.
68. 68 Agnelli, G., Buller, H.R., Cohen, A., et al. Apixaban for extended treatment of venous thromboembolism. N Engl J Med 368 (2013), 699–708.
69. 69 Beam, D.M., Kahler, Z.P., Kline, J.A., Hiestand, B.C., Immediate discharge and home treatment with rivaroxaban of low-risk venous thromboembolism diagnosed in two U.S. emergency departments: a one-year preplanned analysis. Acad Emerg Med 22 (2015), 788–795.
70. 70 Remy-Jardin, M., Pistolesi, M., Goodman, L.R., Gefter, W.B., Gottschalk, A., Mayo, J.R., et al. Management of suspected acute pulmonary embolism in the era of CT angiography: a statement from the Fleischner Society. Radiology 245 (2007), 315–329.
71. 71 Torbicki, A., Perrier, A., Konstantinides, S., et al. Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 29 (2008), 2276–2315.
72. 72 Prasad, V., Rho, J., Cifu, A., The diagnosis and treatment of pulmonary embolism. A metaphor for medicine in the evidence-based medicine era. Arch Intern Med 172 (2012), 955–958.
73. 73 Donato, A.A., Khoche, S., Santora, J., Wagner, B., Clinical outcomes in patients with isolated subsegmental pulmonary emboli diagnosed by multidetector CT pulmonary angiography. Thromb Res 126 (2010), e266–e270.
74. 74 Stein, P.D., Goodman, L.R., Hull, R.D., Dalen, J.E., Matta, F., Diagnosis and management of isolated subsegmental pulmonary embolism: review and assessment of the options. Clin Appl Thromb Hemost 18 (2012), 20–26.
75. 75 Wysowski, D.K., Nourjah, P., Swartz, L., Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action. Arch Intern Med 167 (2007), 1414–1419.
76. 76 Hess, E.P., Knoedler, M.A., Shah, N.D., et al. The chest pain choice decision aid: a randomized trial. Circ Cardiovasc Qual Outcomes 5 (2012), 251–259.
77. 77 Singh, B., Mommer, S.K., Erwin, P.J., et al. Pulmonary embolism rule-out criteria (PERC) in pulmonary embolism–revisited: a systematic review and meta-analysis. Emerg Med J 30 (2013), 701–706.
78. 78 Fesmire, F.M., Brown, M.D., Espinosa, J.A., et al. Critical issues in the evaluation and management of adult patients presenting to the emergency department with suspected pulmonary embolism. Ann Emerg Med 57 (2011), 628–652.
79. 79 Penaloza, A., Verschuren, F., Dambrine, S., et al. Performance of the pulmonary embolism rule-out criteria (the PERC rule) combined with low clinical probability in high prevalence population. Thromb Res 129 (2012), e189–e193.
80. 80 Bokobza, J., Aubry, A., Nakle, N., et al. Pulmonary embolism rule-out criteria vs D-dimer testing in low-risk patients for pulmonary embolism: a retrospective study. Am J Emerg Med 32 (2014), 609–613.
81. 81 Couturaud, F., Kearon, C., Bates, S.M., Ginsberg, J.S., Decrease in sensitivity of D-dimer for acute venous thromboembolism after starting anticoagulant therapy. Blood Coagul Fibrinolysis 13 (2002), 241–246.
82. 82 Taira, T., Taira, B.R., Carmen, M., et al. Risk of venous thromboembolism in patients with borderline quantitative D-dimer levels. Am J Emerg Med 28 (2010), 450–453.
83. 83 Kutinsky, I., Blakley, S., Roche, V., Normal D-dimer levels in patients with pulmonary embolism. Arch Intern Med 159 (1999), 1569–1572.
84. 84 Runyon, M.S., Gellar, M.A., Sanapareddy, N., et al. Development and comparison of a minimally-invasive model of autologous clot pulmonary embolism in Sprague-Dawley and Copenhagen rats. Thromb J, 8, 2010, 3.
85. 85 Schouten, H.J., Geersing, G.J., Koek, H.L., et al. Diagnostic accuracy of conventional or age adjusted D-dimer cut-off values in older patients with suspected venous thromboembolism: systematic review and meta-analysis. BMJ, 346, 2013, f2492.
86. 86 Righini, M., Van Es, J., Den Exter, P.L., et al. Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study. JAMA 311 (2014), 1117–1124.